» Articles » PMID: 31300671

Insulin Resistance and Metabonomics Analysis of Fatty Liver Haemorrhagic Syndrome in Laying Hens Induced by a High-energy Low-protein Diet

Overview
Journal Sci Rep
Specialty Science
Date 2019 Jul 14
PMID 31300671
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Fatty liver haemorrhagic syndrome (FLHS) is a widespread metabolic disease in laying hens that causes a decrease in egg production and even death. Insulin resistance is a major contributor to the pathogenesis of nonalcoholic fatty liver disease. However, the relationship between FLHS and the insulin resistance mechanisms underlying FLHS is not well elucidated. Therefore, we established an FLHS model induced by feeding a high-energy low-protein diet. In the current study, we found that the fasting glucose and insulin concentrations were elevated in the FLHS group compared with the control group during the experimental period. The results of the oral glucose tolerance test (OGTT) and insulin sensitivity test (IST) showed a high level of insulin resistance in the FLHS model. InsR, 4EBP-1, Glut-1 and Glut-3 mRNA expression were decreased, and TOR, S6K1, and FOXO1 were elevated (P < 0.05). Metabolomic analysis with GC/MS identified 46 differentially expressed metabolites between these two groups, and of these, 14 kinds of metabolism molecules and 32 kinds of small metabolism molecules were decreased (P < 0.05). Further investigation showed that glucose, lipid and amino acid metabolism blocks in the progression of FLHS by GO functional and pathway analysis. Overall, these results suggest that insulin resistance participated in FLHS; comprehensively, metabolites participated in the dysregulated biological process.

Citing Articles

Protective effects of betaine on the early fatty liver in laying hens through ameliorating lipid metabolism and oxidative stress.

Wang C, Sun X, Liu X, Wang Y, Luo J, Yang X Front Nutr. 2024; 11:1505357.

PMID: 39654538 PMC: 11627039. DOI: 10.3389/fnut.2024.1505357.


Glucose Metabolism-Modifying Natural Materials for Potential Feed Additive Development.

Lin W, Hoe B, Li X, Lian D, Zeng X Pharmaceutics. 2024; 16(9).

PMID: 39339244 PMC: 11435105. DOI: 10.3390/pharmaceutics16091208.


Probiotics and Non-Alcoholic Fatty Liver Disease: Unveiling the Mechanisms of and in Modulating Lipid Metabolism, Inflammation, and Intestinal Barrier Integrity.

Lu J, Shataer D, Yan H, Dong X, Zhang M, Qin Y Foods. 2024; 13(18).

PMID: 39335920 PMC: 11431124. DOI: 10.3390/foods13182992.


Hepatoprotective effects of magnolol in fatty liver hemorrhagic syndrome hens through shaping gut microbiota and tryptophan metabolic profile.

Lv Y, Ge C, Wu L, Hu Z, Luo X, Huang W J Anim Sci Biotechnol. 2024; 15(1):120.

PMID: 39238062 PMC: 11378483. DOI: 10.1186/s40104-024-01074-9.


Exploring Bile-Acid Changes and Microflora Profiles in Chicken Fatty Liver Disease Model.

Yang W, Chang P, Li S, Ding S, Lin Y Animals (Basel). 2024; 14(7).

PMID: 38612231 PMC: 11011030. DOI: 10.3390/ani14070992.


References
1.
Mesnage R, Renney G, Seralini G, Ward M, Antoniou M . Multiomics reveal non-alcoholic fatty liver disease in rats following chronic exposure to an ultra-low dose of Roundup herbicide. Sci Rep. 2017; 7:39328. PMC: 5220358. DOI: 10.1038/srep39328. View

2.
Welch Jr K, Allalou A, Sehgal P, Cheng J, Ashok A . Glucose transporter expression in an avian nectarivore: the ruby-throated hummingbird (Archilochus colubris). PLoS One. 2013; 8(10):e77003. PMC: 3796544. DOI: 10.1371/journal.pone.0077003. View

3.
Zhang J, Zhao Y, Xu C, Hong Y, Lu H, Wu J . Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study. Sci Rep. 2014; 4:5832. PMC: 5376058. DOI: 10.1038/srep05832. View

4.
Dupont J, Tesseraud S, Derouet M, Collin A, Rideau N, Crochet S . Insulin immuno-neutralization in chicken: effects on insulin signaling and gene expression in liver and muscle. J Endocrinol. 2008; 197(3):531-42. DOI: 10.1677/JOE-08-0055. View

5.
Shimo N, Matsuoka T, Miyatsuka T, Takebe S, Tochino Y, Takahara M . Short-term selective alleviation of glucotoxicity and lipotoxicity ameliorates the suppressed expression of key β-cell factors under diabetic conditions. Biochem Biophys Res Commun. 2015; 467(4):948-54. DOI: 10.1016/j.bbrc.2015.10.038. View